Enhanced CAR T cell therapy offers new strategy for lymphoma

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

from Latest Science News -- ScienceDaily https://ift.tt/oKJbH7i

Comments

Popular posts from this blog

New method to detect and visualize sperm cells recovered from forensic evidence